BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20679994)

  • 1. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
    Domené HM; Scaglia PA; Jasper HG
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-labile subunit (ALS) deficiency.
    Domené HM; Hwa V; Jasper HG; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):101-13. PubMed ID: 21396577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
    Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
    Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.
    Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A
    J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse.
    Domené HM; Bengolea SV; Jasper HG; Boisclair YR
    J Endocrinol Invest; 2005; 28(5 Suppl):43-6. PubMed ID: 16114275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
    Domené HM; Scaglia PA; Lteif A; Mahmud FH; Kirmani S; Frystyk J; Bedecarrás P; Gutiérrez M; Jasper HG
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4444-50. PubMed ID: 17726072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
    Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.
    Fofanova-Gambetti OV; Hwa V; Kirsch S; Pihoker C; Chiu HK; Högler W; Cohen LE; Jacobsen C; Derr MA; Rosenfeld RG
    Horm Res; 2009; 71(2):100-10. PubMed ID: 19129715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system.
    Domené HM; Scaglia PA; Martínez AS; Keselman AC; Karabatas LM; Pipman VR; Bengolea SV; Guida MC; Ropelato MG; Ballerini MG; Lescano EM; Blanco MA; Heinrich JJ; Rey RA; Jasper HG
    Horm Res Paediatr; 2013; 80(6):413-23. PubMed ID: 24335034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel
    Işık E; Haliloglu B; van Doorn J; Demirbilek H; Scheltinga SA; Losekoot M; Wit JM
    Eur J Endocrinol; 2017 Jun; 176(6):657-667. PubMed ID: 28249955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Homozygous Mutation of the Acid-Labile Subunit
    Poyrazoğlu Ş; Hwa V; Baş F; Dauber A; Rosenfeld R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):432-438. PubMed ID: 30717585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure.
    Hwa V; Haeusler G; Pratt KL; Little BM; Frisch H; Koller D; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 May; 91(5):1826-31. PubMed ID: 16507628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of acid-labile subunit (ALS) in the modulation of GH-IGF-I action.
    Domené S; Domené HM
    Mol Cell Endocrinol; 2020 Dec; 518():111006. PubMed ID: 32861700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency.
    Scaglia PA; Keselman AC; Braslavsky D; Martucci LC; Karabatas LM; Domené S; Gutiérrez ML; Ballerini MG; Ropelato MG; Spinola-Castro A; Siviero-Miachon AA; Tartuci JS; Rodríguez Azrak MS; Rey RA; Jasper HG; Bergadá I; Domené HM
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):300-311. PubMed ID: 28445628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type).
    Fowlkes JL; Bunn RC; Coleman HN; Hall B; Reid MC; Thrailkill KM
    Growth Horm IGF Res; 2007 Oct; 17(5):399-407. PubMed ID: 17560154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
    Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
    J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1).
    Hess O; Khayat M; Hwa V; Heath KE; Teitler A; Hritan Y; Allon-Shalev S; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):838-44. PubMed ID: 23488611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.